Finance

Lists
Why is ENOV up 2,49%?
Dive Deeper
ENOV:NYSE
Enovis Corp
18,13 US$
+2,49%
(+0,44) 1D
12 ოქტ, 13:49:51 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENOV...
Open
17,47 US$
High
18,32 US$
Low
17,36 US$
Mkt. cap
1,05 მლრდ.
Avg. vol.
1,94 მლნ.
Volume
268,04 ათ.
52-wk high
34,28 US$
52-wk low
16,70 US$
EPS
-19,27 US$
Beta
1,14
Shares outstanding
57,67 მლნ.
No. of employees
8 ათ.
Open
17,47 US$
High
18,32 US$
Low
17,36 US$
Mkt. cap
1,05 მლრდ.
Avg. vol.
1,94 მლნ.
Volume
268,04 ათ.
52-wk high
34,28 US$
52-wk low
16,70 US$
EPS
-19,27 US$
Beta
1,14
Shares outstanding
57,67 მლნ.
No. of employees
8 ათ.
News stories
From web sources and news partners
Investing.com
Investing.com
·
6 საათის წინ
Needham cuts Enovis stock price target on robotics deal impact
Simply Wall Street
Simply Wall Street
·
1 დღის წინ
Enovis (ENOV) Stock Looks Undervalued Based On Future Cash Flow
Yahoo Finance Singapore
Yahoo Finance Singapore
·
2 დღის წინ
Enovis (ENOV), Why Is Fresh Attention Building Now?
Profile
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Dallas, Texas and is listed on the NYSE as ENOV. The company has over 8,000 employees operating at 30 sites around the world. Wikipedia
About Enovis Corp
CEOმეთიუ ელ ტრეროტოლა
Employees7,8 ათ.
Founded1995
Headquartersუილმინგტონი, დელავერის შტატი, ამერიკის შეერთებული შტატები
SectorMedical device
Websiteenovis.com
Analyst ratings
Based on 12 analysts giving stock ratings to ENOV in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ENOV in the last 3 months.
Highest
Current 18,13 US$
47,00 US$ (+159,24%)
Average
36,55 US$ (+101,60%)
Lowest
27,00 US$ (+48,92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Matson
Needham
Buy
Maintained
34,00 US$
+87,5%
10/12/2026
Patrick Wood
UBS
Buy
Maintained
44,00 US$
+142,7%
10/05/2026
Ryan Zimmerman
BTIG
Buy
Maintained
36,00 US$
+98,6%
10/02/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
33,00 US$
+82%
09/08/2026
Caitlin Cronin
Canaccord Genuity
Buy
Reiterated
45,00 US$
+148,2%
09/01/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
45,00 US$
+148,2%
09/01/2026
David Turkaly
Citizens JMP
Buy
Maintained
47,00 US$
+159,2%
09/02/2026
Vik Chopra
BMO Capital
Buy
Reiterated
27,00 US$
+48,9%
09/01/2026
Keith Hinton
Freedom Capital Markets
Buy
Maintained
36,00 US$
+98,6%
09/01/2026
Steven Lichtman
William Blair
Buy
Maintained
-
-
08/14/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
28,00 US$
+54,4%
08/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
32,00 US$
+76,5%
08/07/2026
Rong Li
Jefferies
Buy
Reiterated
40,00 US$
+120,6%
07/14/2026
Unknown Analyst
Jefferies
Buy
Reiterated
40,00 US$
+120,6%
07/14/2026
Unknown Analyst
BMO Capital
Buy
Initiated
29,00 US$
+60%
07/09/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
37,00 US$
+104,1%
05/08/2026
Last report
6 აგვ. 2026
Fiscal period
Q2 2026
0,90 US$ / 0,85 US$
+6,34%beat
Revenue / Est. (USD)
582,78 მლნ. / 581,84 მლნ.
+0,16%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ოქტ. 2025
დეკ. 2025
აპრ. 2026
ივლ. 2026
Revenue
548,91 მლნ.
575,76 მლნ.
589,15 მლნ.
582,78 მლნ.
Cost of goods sold
218,50 მლნ.
222,69 მლნ.
223,67 მლნ.
223,53 მლნ.
Cost of revenue
218,50 მლნ.
222,69 მლნ.
223,67 მლნ.
223,53 მლნ.
Research and development expenses
29,74 მლნ.
31,36 მლნ.
31,53 მლნ.
31,69 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245,42 მლნ.
249,84 მლნ.
270,58 მლნ.
261,61 მლნ.
Operating expense
318,85 მლნ.
326,38 მლნ.
344,02 მლნ.
334,86 მლნ.
Total operating expenses
537,35 მლნ.
549,08 მლნ.
567,69 მლნ.
558,39 მლნ.
Operating income
11,56 მლნ.
26,68 მლნ.
21,46 მლნ.
24,39 მლნ.
Other non operating income
448,00 ათ.
1,93 მლნ.
3,27 მლნ.
-1,91 მლნ.
EBT including unusual items
-566,87 მლნ.
-509,55 მლნ.
634,00 ათ.
7,46 მლნ.
EBT excluding unusual items
3,18 მლნ.
21,10 მლნ.
15,57 მლნ.
14,44 მლნ.
Income tax expense
4,00 მლნ.
9,26 მლნ.
9,04 მლნ.
8,50 მლნ.
Effective tax rate
-0,71%
-1,82%
1 426,66%
113,88%
Other operating expenses
-
-
-
-
Net income
-571,15 მლნ.
-520,59 მლნ.
-8,76 მლნ.
-1,19 მლნ.
Net profit margin
-104,05%
-90,42%
-1,49%
-0,20%
Earnings per share
0,75
0,95
0,89
0,90
Interest and investment income
12,00 მლნ.
12,60 მლნ.
10,00 მლნ.
10,50 მლნ.
Interest expense
-20,83 მლნ.
-20,11 მლნ.
-19,17 მლნ.
-18,54 მლნ.
Net interest expenses
-8,83 მლნ.
-7,51 მლნ.
-9,17 მლნ.
-8,04 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
85,94 მლნ.
103,69 მლნ.
94,82 მლნ.
95,42 მლნ.
Gain or loss from assets sale
281,00 ათ.
329,00 ათ.
-75,00 ათ.
843,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები